The miR-17-92 cluster is a group of microRNAs that play critical roles in both development and disease. These miRNAs are known to act as oncogenes, promoting cell proliferation, suppressing apoptosis, and inducing tumor angiogenesis. Recent studies have shown that these miRNAs are also essential for normal development of the heart, lungs, and immune system. The miR-17-92 cluster is located in the third intron of the C13orf25 gene and encodes six miRNAs. It is highly conserved across vertebrates and has paralogs, including the miR-106b-25 and miR-106a-363 clusters. These miRNAs are involved in various cellular processes, including cell cycle regulation, apoptosis, and tumor formation. In cancer, the miR-17-92 cluster is associated with several types of lymphoma and solid tumors. Its expression is often amplified in these cancers, and its overexpression can promote tumor growth and progression. The miR-17-92 cluster is also linked to the E2F family of transcription factors, which are critical regulators of the cell cycle and apoptosis. These miRNAs can regulate the expression of E2F proteins, which can influence cell proliferation and survival. In development, the miR-17-92 cluster is essential for the proper development of the heart, lungs, and immune system. Deletion of the miR-17-92 cluster in mice leads to severe developmental defects, including reduced lung development and heart defects. These miRNAs also play a role in B cell development, where they are involved in the survival and differentiation of B cells. The miR-17-92 cluster has also been shown to regulate the expression of the pro-apoptotic gene Bim, which is involved in cell death. Loss of miR-17-92 can lead to increased apoptosis, which can contribute to disease progression. Additionally, these miRNAs can influence the expression of other genes, such as Pten, a tumor suppressor gene. The miR-17-92 cluster is a key player in both normal development and cancer. Its functions are complex and involve multiple pathways, including cell cycle regulation, apoptosis, and tumor formation. Further research is needed to fully understand the roles of these miRNAs and their potential as therapeutic targets in cancer.The miR-17-92 cluster is a group of microRNAs that play critical roles in both development and disease. These miRNAs are known to act as oncogenes, promoting cell proliferation, suppressing apoptosis, and inducing tumor angiogenesis. Recent studies have shown that these miRNAs are also essential for normal development of the heart, lungs, and immune system. The miR-17-92 cluster is located in the third intron of the C13orf25 gene and encodes six miRNAs. It is highly conserved across vertebrates and has paralogs, including the miR-106b-25 and miR-106a-363 clusters. These miRNAs are involved in various cellular processes, including cell cycle regulation, apoptosis, and tumor formation. In cancer, the miR-17-92 cluster is associated with several types of lymphoma and solid tumors. Its expression is often amplified in these cancers, and its overexpression can promote tumor growth and progression. The miR-17-92 cluster is also linked to the E2F family of transcription factors, which are critical regulators of the cell cycle and apoptosis. These miRNAs can regulate the expression of E2F proteins, which can influence cell proliferation and survival. In development, the miR-17-92 cluster is essential for the proper development of the heart, lungs, and immune system. Deletion of the miR-17-92 cluster in mice leads to severe developmental defects, including reduced lung development and heart defects. These miRNAs also play a role in B cell development, where they are involved in the survival and differentiation of B cells. The miR-17-92 cluster has also been shown to regulate the expression of the pro-apoptotic gene Bim, which is involved in cell death. Loss of miR-17-92 can lead to increased apoptosis, which can contribute to disease progression. Additionally, these miRNAs can influence the expression of other genes, such as Pten, a tumor suppressor gene. The miR-17-92 cluster is a key player in both normal development and cancer. Its functions are complex and involve multiple pathways, including cell cycle regulation, apoptosis, and tumor formation. Further research is needed to fully understand the roles of these miRNAs and their potential as therapeutic targets in cancer.